Question 1

Does Barclays own ACRS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 73,010 shares of ACRS (Aclaris Therapeutics), worth $386,223.

Question 2

How many shares of ACRS does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 73,010 shares of ACRS (Aclaris Therapeutics).

Question 3

What is Barclays' ACRS position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' ACRS position is worth $386,223.

Question 4

Is Barclays buying or selling ACRS?

Accepted Answer

In Q2 2026, Barclays increased its ACRS position from 21,508 to 73,010 shares.

Question 5

When did Barclays first buy ACRS?

Accepted Answer

Barclays first reported ACRS in its Q1 2019 13F and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	73,010	+239.5%	$386,223	0.0%	$5.29	38
2026-Q1	Decreased	21,508	-85.0%	$80,654	0.0%	$3.75	0
2025-Q4	Increased	143,414	+16.2%	$431,677	0.0%	$3.01	28
2025-Q3	Decreased	123,425	-21.1%	$234,508	0.0%	$1.90	0
2025-Q2	Increased	156,337	+31.4%	$221,998	0.0%	$1.42	29
2025-Q1	Increased	119,001	+682.9%	$182,072	0.0%	$1.53	37
2024-Q4	Decreased	15,201	-25.5%	$37,698	0.0%	$2.48	0
2024-Q3	Decreased	20,393	-49.3%	$23,452	0.0%	$1.15	0